Clinical Trial Update: A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of ADC3680 in inadequately-controlled asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ADC3680

Snippet

Sponsor: Pulmagen Therapeutics | Conditions: Asthma | Phase 2 | Status: COMPLETED